GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Branded Legacy Inc (OTCPK:BLEG) » Definitions » Debt-to-EBITDA

Branded Legacy (Branded Legacy) Debt-to-EBITDA : 0.76 (As of Dec. 2021)


View and export this data going back to . Start your Free Trial

What is Branded Legacy Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Branded Legacy's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was $0.01 Mil. Branded Legacy's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was $0.42 Mil. Branded Legacy's annualized EBITDA for the quarter that ended in Dec. 2021 was $0.58 Mil. Branded Legacy's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2021 was 0.76.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Branded Legacy's Debt-to-EBITDA or its related term are showing as below:

BLEG's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.69
* Ranked among companies with meaningful Debt-to-EBITDA only.

Branded Legacy Debt-to-EBITDA Historical Data

The historical data trend for Branded Legacy's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Branded Legacy Debt-to-EBITDA Chart

Branded Legacy Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-EBITDA
Get a 7-Day Free Trial -1.00 -0.07 -0.11 -0.53 -1.39

Branded Legacy Quarterly Data
Dec15 Dec16 Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 -1.08 -0.75 -0.29 0.76

Competitive Comparison of Branded Legacy's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Branded Legacy's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Branded Legacy's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Branded Legacy's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Branded Legacy's Debt-to-EBITDA falls into.



Branded Legacy Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Branded Legacy's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.014 + 0.421) / -0.314
=-1.39

Branded Legacy's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.014 + 0.421) / 0.576
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2021) EBITDA data.


Branded Legacy  (OTCPK:BLEG) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Branded Legacy Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Branded Legacy's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Branded Legacy (Branded Legacy) Business Description

Traded in Other Exchanges
N/A
Address
227 West 4th Street, Unit 108, Charlotte, NC, USA, 28202
Branded Legacy Inc is a company engaged in the development and marketing of products for the fitness and wellness markets. The company is focused on creating products for health-conscious consumers. Through its subsidiary, the company focuses on the development and marketing of hemp-based food, beverage, and healthcare products including hemp coffee, hemp water, and hemp-based skincare products. It sells product to consumers, wholesalers as well as distributors.